0
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Antifungal resistance in dermatophytes – review of the epidemiology, diagnostic challenges and treatment strategies for managing trichophyton indotineae infections

, , , , , , , , , , & show all
Received 03 Jun 2024, Accepted 06 Aug 2024, Accepted author version posted online: 08 Aug 2024
Accepted author version

REFERENCES

  • Verma SB, Panda S, Nenoff P, et al. The unprecedented epidemic-like scenario of dermatophytosis in India: I. Epidemiology, risk factors and clinical features. Indian J Dermatol Venereol Leprol. 2021;87:154–175 10.25259/IJDVL_301_20
  • Verma SB, Panda S, Nenoff P, et al. The unprecedented epidemic-like scenario of dermatophytosis in India: II. Diagnostic methods and taxonomical aspects. Indian J Dermatol Venereol Leprol. 2021;87:326–332 10.25259/IJDVL_302_20
  • Verma SB, Panda S, Nenoff P, et al. The unprecedented epidemic-like scenario of dermatophytosis in India: III. Antifungal resistance and treatment options. Indian J Dermatol Venereol Leprol. 2021;87:468–482 10.25259/IJDVL_303_20
  • Tang C, Ahmed SA, Deng S, et al. Detection of emerging genotypes in Trichophyton mentagrophytes species complex: A proposal for handling biodiversity in dermatophytes. Front Microbiol. 2022;13:960190 10.3389/fmicb.2022.960190
  • Jabet A, Normand AC, Brun S, et al. Trichophyton indotineae, from epidemiology to therapeutic. J Med Mycol. 2023;33
  • Xie W, Kong X, Zheng H, et al. Rapid emergence of recalcitrant dermatophytosis caused by a cluster of multidrug-resistant trichophyton indotineae in China. Br J Dermatol. 2024;190(4):585–587. doi: 10.1093/bjd/ljae009
  • Nenoff P, Verma SB, Ebert A, et al. Spread of terbinafine-resistant Trichophyton mentagrophytes type VIII (India) in Germany–“the tip of the iceberg?” J Fungi. 2020;6:1–20
  • Caplan, AS, Todd, GC, Zhu, Y, et al. Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae. JAMA dermatology. 2024;e241126
  • Gupta AK, Venkataraman M, Hall DC, et al. The emergence of trichophyton indotineae: implications for clinical practice. Int J Dermatol. 2023;62(7):857–861. doi: 10.1111/ijd.16362
  • Chowdhary A, Singh A, Kaur A, et al. The emergence and worldwide spread of the species trichophyton indotineae causing difficult-to-treat dermatophytosis: a new challenge in the management of dermatophytosis. PloS Pathog. 2022;18(9):1–11. doi: 10.1371/journal.ppat.1010795
  • Fukada N, Kobayashi H, Nakazono M, et al. A case of tinea faciei due to trichophyton indotineae with steroid rosacea related to topical over-the-counter drugs purchased outside of Japan. Med Mycol J. 2024;65(1):23–26. doi: 10.3314/mmj.23-00014
  • Caplan AS, Chaturvedi S, Zhu Y, et al. Notes from the Field: First Reported U.S. Cases of Tinea Caused by Trichophyton indotineae - New York City, December 2021-March 2023. Morb Mortal Wkly Rep. 2023;72:536–537
  • Caplan AS, Zakhem GA, Pomeranz MK. Trichophyton mentagrophytes internal transcribed spacer genotype VIII. JAMA Dermatol. 2023;159(10):1130. doi: 10.1001/jamadermatol.2023.2645
  • Abastabar M, Babaei M, Mohammadi R, et al. Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of Two Strains with a Novel Mutation in SQLE Gene with Homology Modeling. Mycopathologia. 2022;188:449–460
  • Kolarczyková D, Lysková P, Švarcová M, et al. Terbinafine resistance in Trichophyton mentagrophytes and Trichophyton rubrum in the Czech Republic: a prospective multicentric study. Mycoses. 2024;67(2):e13708. doi: 10.1111/myc.13708
  • Brasch J, Gräser Y, Beck-Jendroscheck V, et al. “Indian” strains of Trichophyton mentagrophytes with reduced itraconazole susceptibility in Germany. J Ger Soc Dermatology. 2021;19:1723–1727
  • Gawaz A, Nenoff P, Uhrlaß S, et al. Treatment of a terbinafine-resistant trichophyton mentagrophytes type VIII. Hautarzt. 2021;72(10):900–904. doi: 10.1007/s00105-021-04857-7
  • Jabet A, Brun S, Normand AC, et al. Extensive dermatophytosis caused by terbinafine-resistant Trichophyton indotineae, France. Emerg Infect Dis. 2022;28:229–33
  • Dellière S, Joannard B, Benderdouche M, et al. Emergence of difficult-to-treat tinea corporis caused by trichophyton mentagrophytes complex isolates, Paris, France. Emerg Infect Dis. 2022;28(1):224–228. doi: 10.3201/eid2801.210810
  • Crotti S, Cruciani D, Spina S, et al. A terbinafine sensitive Trichophyton indotineae strain in Italy: The first clinical case of tinea corporis and onychomycosis. J Fungi. 2023;9:1–8
  • Messina F, Santiso G, Romero M, et al. First case report of tinea corporis caused by Trichophyton indotineae in Latin America. Med Mycol Case Rep. 2023;41:48–51 10.1016/j.mmcr.2023.08.004
  • Abdolrasouli A, Borman AM, Johnson EM, et al. Terbinafine-resistant Trichophyton indotineae causing extensive dermatophytosis in a returning traveller, London, United Kingdom. Clin Exp Dermatol. 2024;llae042
  • Jia S, Long X, Hu W, et al. The epidemic of the multiresistant dermatophyte Trichophyton indotineae has reached China. Front Immunol. 2023;13:1113065 10.3389/fimmu.2022.1113065
  • Spivack S, Gold JAW, Lockhart SR, et al. Potential sexual transmission of antifungal-resistant trichophyton indotineae. Emerg Infect Dis. 2024;30(4):807–809. doi: 10.3201/eid3004.240115
  • Kupsch C, Czaika V-A, Deutsch C, et al. Trichophyton mentagrophytes - a new genotype of zoophilic dermatophyte causes sexually transmitted infections. J Dtsch Dermatol Ges. 2019;17:493–501
  • Jabet A, Dellière S, Seang S, et al. Sexually transmitted trichophyton mentagrophytes genotype VII infection among men who have sex with men. Emerg Infect Dis. 2023;29(7):1411–1414. doi: 10.3201/eid2907.230025
  • Chermette R, Ferreiro L, Guillot J. Dermatophytoses in animals. Mycopathologia. 2008;166(5–6):385–405. doi: 10.1007/s11046-008-9102-7
  • Nenoff P, Uhrlaß S, Verma SB, et al. Trichophyton mentagrophytes ITS genotype VIII and trichophyton indotineae: a terminological maze, or is it? Indian J Dermatol Venereol Leprol. 2022;88:586–589. doi: 10.25259/IJDVL_112_2022
  • Rudramurthy SM, Shaw D, Shankarnarayan SA, et al. Comprehensive Taxonomical Analysis of Trichophyton mentagrophytes/interdigitale Complex of Human and Animal Origin from India. J fungi (Basel, Switzerland). 2023;9:577
  • Kumar M, Thomas P, Athira V, et al. Molecular epidemiology of Trichophyton infections among canines from Northern India. J Med Mycol. 2023;33:101352
  • Oladzad V, Nasrollahi Omran A, Haghani I, et al. Multi-drug resistance Trichophyton indotineae in a stray dog. Res Vet Sci. 2024;166:105105 10.1016/j.rvsc.2023.105105
  • Tang C, Kong X, Ahmed SA, et al. Taxonomy of the trichophyton mentagrophytes/T. interdigitale species complex harboring the highly virulent, multiresistant genotype T. indotineae. Mycopathologia. 2021;186(3):315–326. doi: 10.1007/s11046-021-00544-2
  • Dogra S, Narang T. Emerging atypical and unusual presentations of dermatophytosis in India. Clin Dermatology Rev. 2017;1:12
  • Atzori L, Pau M, Aste N, et al. Dermatophyte infections mimicking other skin diseases: a 154-person case survey of tinea atypica in the district of cagliari (Italy). Int J Dermatol. 2012;51(4):410–415. doi: 10.1111/j.1365-4632.2011.05049.x
  • Heidemann S, Monod M, Gräser Y. Signature polymorphisms in the internal transcribed spacer region relevant for the differentiation of zoophilic and anthropophilic strains of trichophyton interdigitale and other species of T. mentagrophytes sensu lato. Br J Dermatol. 2010;162(2):282–295. doi: 10.1111/j.1365-2133.2009.09494.x
  • Kano R, Kimura U, Kakurai M, et al. Trichophyton indotineae sp. nov.: a new highly terbinafine-resistant anthropophilic dermatophyte species. Mycopathologia. 2020;185(6):947–958. doi: 10.1007/s11046-020-00455-8
  • Kumar P, Das S, Tigga R, et al. Whole genome sequences of two trichophyton indotineae clinical isolates from India emerging as threats during therapeutic treatment of dermatophytosis. 3 Biotech. 2021;11(9):402. doi: 10.1007/s13205-021-02950-1
  • Švarcová M, Větrovský T, Kolařík M, et al. Defining the relationship between phylogeny, clinical manifestation, and phenotype for trichophyton mentagrophytes/interdigitale complex; a literature review and taxonomic recommendations. Med Mycol. 2023;61(5):myad042. doi: 10.1093/mmy/myad042
  • Chowdhary A, Singh A, Singh PK, et al. Perspectives on misidentification of trichophyton interdigitale/trichophyton mentagrophytes using internal transcribed spacer region sequencing: urgent need to update the sequence database. Mycoses. 2019;62(1):11–15. doi: 10.1111/myc.12865
  • Mirhendi H, Makimura K, de Hoog GS, et al. Translation elongation factor 1-α gene as a potential taxonomic and identification marker in dermatophytes. Med Mycol. 2015;53(3):215–224. doi: 10.1093/mmy/myu088
  • Singh A, Singh P, Dingemans G, et al. Evaluation of DermaGenius® resistance real-time polymerase chain reaction for rapid detection of terbinafine-resistant trichophyton species. Mycoses. 2021;64(7):721–726. doi: 10.1111/myc.13271
  • Persinoti GF, Martinez DA, Li W, et al. Whole-genome analysis illustrates global clonal population structure of the ubiquitous dermatophyte pathogen trichophyton rubrum. Genetics. 2018;208(4):1657–1669. doi: 10.1534/genetics.117.300573
  • Singh A, Masih A, Monroy-Nieto J, et al. A unique multidrug-resistant clonal Trichophyton population distinct from Trichophyton mentagrophytes/Trichophyton interdigitale complex causing an ongoing alarming dermatophytosis outbreak in India: Genomic insights and resistance profile. Fungal Genet Biol. 2019;133:103266 10.1016/j.fgb.2019.103266
  • Deng R, Wang X, Li R Dermatophyte infection: from fungal pathogenicity to host immune responses. Front Immunol. 2023;14:1285887 10.3389/fimmu.2023.1285887
  • Normand A-C, Moreno-Sabater A, Jabet A, et al. MALDI-TOF Mass Spectrometry Online Identification of Trichophyton indotineae Using the MSI-2 Application. J fungi (Basel, Switzerland). 2022;8:1103
  • De Paepe R, Normand AC, Uhrlaß S, et al. Resistance profile, terbinafine resistance screening and MALDI-TOF MS identification of the emerging pathogen Trichophyton indotineae. Mycopathologia. 2024;189:1–11
  • Gupta AK, Cooper EA, Wang T, et al. Detection of squalene epoxidase mutations in United States patients with Onychomycosis: implications for management. J Invest Dermatol. 2023;143(12):2476–2483.e7. doi: 10.1016/j.jid.2023.04.032
  • Batvandi A, Pchelin IM, Kiasat N, et al. Time and cost-efficient identification of trichophyton indotineae. Mycoses. 2023;66(1):75–81. doi: 10.1111/myc.13530
  • Shenoy MM, Rengasamy M, Dogra S, et al. A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India. Mycoses. 2022;65(1):13–23. doi: 10.1111/myc.13360
  • Domínguez-Gil Hurlé A, Sánchez Navarro A, García Sánchez MJ. Therapeutic drug monitoring of itraconazole and the relevance of pharmacokinetic interactions. Clin Microbiol Infect. 2006;12:97–106
  • Pasqualotto AC, Denning DW. Generic substitution of itraconazole resulting in sub-therapeutic levels and resistance. Int J Antimicrob Agents. 2007;30(1):93–94. doi: 10.1016/j.ijantimicag.2006.11.027
  • Triboandas H, Pitt K, Bezerra M, et al. Itraconazole amorphous solid dispersion tablets: formulation and compaction process optimization using quality by design principles and tools. Pharmaceutics. 2022;14(11):2398. doi: 10.3390/pharmaceutics14112398
  • McCormick TS, Ghannoum M. Time to Think Antifungal Resistance Increased Antifungal Resistance Exacerbates the Burden of Fungal Infections Including Resistant Dermatomycoses. Pathog Immun. 2023;8:158–176
  • Wiederhold NP. Antifungal Susceptibility Testing of Dermatophytes. Dermatophytes and Dermatophytoses. Cham: Springer International Publishing; 2021. p. 401–414
  • Blanchard G, Amarov B, Fratti M, et al. Reliable and rapid identification of terbinafine resistance in dermatophytic nail and skin infections. J Eur Acad Dermatology Venereol. 2023;37:2080–2089
  • Cañete-Gibas CF, Mele J, Patterson HP, et al. Terbinafine-resistant dermatophytes and the presence of Trichophyton indotineae in North America. J Clin Microbiol. 2023;61:1–11 10.1128/jcm.00562-23
  • Kruithoff C, Gamal A, McCormick TS, et al. Dermatophyte Infections Worldwide: Increase in Incidence and Associated Antifungal Resistance. Life (Basel, Switzerland). 2023;14:1
  • Dashti Y, Alobaid K, Al-Rashidi S, et al. Autochthonous case of Trichophyton indotineae in Kuwait. J Med Mycol. 2023;33:1–5
  • Bidaud A-L, Schwarz P, Chowdhary A, et al. In vitro antifungal combination of terbinafine with itraconazole against isolates of trichophyton species. Antimicrob Agents Chemother. 2022;66(1):e0144921. doi: 10.1128/AAC.01449-21
  • Khurana A, Agarwal A, Agrawal D, et al. Multidrug resistant tinea corporis/cruris: Response to voriconazole. J Med Mycol. 2022;32
  • Burmester A, Hipler U, Elsner P, et al. Point mutations in the squalene epoxidase erg1 and sterol 14‐α demethylase erg11 gene of T. indotineae isolates indicate that the resistant mutant strains evolved independently. Mycoses. 2022;65:97–102
  • Pavlović MD, Marzouk S, Bećiri L. Widespread dermatophytosis in a healthy adolescent: the first report of multidrug-resistant Trichophyton indotineae infection in the UAE. Acta dermatovenerologica Alpina, Pannonica, Adriat. 2024;33:53–55
  • Teo JWP, Cheng JWS, Chew KL, et al. Whole genome characterization of trichophyton indotineae isolated in Singapore. Med Mycol. 2024;62(2):myae012. doi: 10.1093/mmy/myae012
  • Yamada T, Yaguchi T, Maeda M, et al. Gene amplification of CYP51B: a new mechanism of resistance to azole compounds in trichophyton indotineae. Antimicrob Agents Chemother. 2022;66(6):e0005922. doi: 10.1128/aac.00059-22
  • Yamada T, Maeda M, Nagai H, et al. Two different types of tandem sequences mediate the overexpression of TinCYP51B in azole-resistant trichophyton indotineae. Antimicrob Agents Chemother. 2023;67(11):e0093323. doi: 10.1128/aac.00933-23
  • Yamada T, Nojo H, Kano R. Long amplification PCR (LA-PCR) detection of azole resistant trichophyton indotineae. Mycopathologia. 2023;188(6):1085–1088. doi: 10.1007/s11046-023-00793-3
  • Gupta AK, Polla Ravi S, Wang T, et al. Antifungal resistance, susceptibility testing and treatment of recalcitrant dermatophytosis caused by trichophyton indotineae: a north American perspective on management. Am J Clin Dermatol. 2023;24(6):927–938. doi: 10.1007/s40257-023-00811-6
  • Russo G, Toutous Trellu L, Fontao L, et al. Towards an early clinical and biological resistance detection in dermatophytosis: About 2 cases of Trichophyton indotineae. J Fungi. 2023;9:1–9
  • Kong X, Song G, Mei H, et al. The domestic isolation of terbinafine- and itraconazole-resistant trichophyton indotineae in Chinese mainland. Mycopathologia. 2023;188(4):383–393. doi: 10.1007/s11046-023-00761-x
  • Villa-Gonzalez JM, Pascual Ares M, López-Soria LM, et al. Extensive tinea corporis caused by Trichophyton indotineae: Report of a case in Spain. J Eur Acad Dermatology Venereol. 2024;38:e22–e23
  • Durdu M, Kandemir H, Karakoyun AS, et al. First terbinafine-resistant trichophyton indotineae isolates with Phe397Leu and/or Thr414His mutations in Turkey. Mycopathologia. 2023;188(3):295–304. doi: 10.1007/s11046-023-00708-2
  • Khurana A, Agarwal A, Singh A, et al. Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris—A prospective trial. Mycoses. 2021;64(12):1480–1488. doi: 10.1111/myc.13367
  • Song G, Kong X, Li X, et al. Prior selection of itraconazole in the treatment of recalcitrant trichophyton indotineae infection: real-world results from retrospective analysis. Mycoses. 2024;67(1):e13663. doi: 10.1111/myc.13663
  • Health Canada. Product Monograph for Itraconazole 100 mg Capsules [Internet]. 2020 [cited 2024 Jul 17]. Available from: https://mintpharma.com/English/pdf/PM mint-itraconazole English.pdf.
  • Khurana A, Sharath S, Sardana K, et al. Clinico-mycological and therapeutic updates on cutaneous dermatophytic infections in the era of Trichophyton indotineae. J Am Acad Dermatol. 2024;S0190–9622
  • Khurana A, Sharath S, Sardana K, et al. Therapeutic Updates on the Management of Tinea Corporis or Cruris in the Era of Trichophyton Indotineae: Separating Evidence from Hype—A Narrative Review. Indian J Dermatol. 2023;68:525–540
  • Gueneau R, Joannard B, Haddad N, et al. Extensive dermatophytosis caused by terbinafine-resistant trichophyton indotineae, successfully treated with topical voriconazole. Int J Antimicrob Agents. 2022;60(5–6):106677. doi: 10.1016/j.ijantimicag.2022.106677
  • Süß A, Uhrlaß S, Ludes A, et al. Extensive tinea corporis due to a terbinafine-resistant trichophyton mentagrophytes isolate of the Indian genotype in a young infant from Bahrain in Germany. Hautarzt. 2019;70(11):888–896. doi: 10.1007/s00105-019-4431-7
  • Thakur R, Kushwaha P, Kalsi AS Tinea universalis due to Trichophyton indotineae in an adult male. Indian J Med Microbiol. 2023;46:1–3 10.1016/j.ijmmb.2023.100476
  • Sacheli R, Hayette M-P. Antifungal Resistance in Dermatophytes: Genetic Considerations, Clinical Presentations and Alternative Therapies. J fungi (Basel, Switzerland). 2021;7:983
  • Mukherjee PK, Leidich SD, Isham N, et al. Clinical trichophyton rubrum strain exhibiting primary resistance to terbinafine. Antimicrob Agents Chemother. 2003;47(1):82–86. doi: 10.1128/AAC.47.1.82-86.2003
  • U.S. Food and Drug Administration. Prescribing Information for VFEND® (voriconazole) [Internet]. 2022 [cited 2024 Apr 25]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021266s053,021267s063,021630s042lbl.pdf.
  • U.S. Food and Drug Administration. Prescribing Information for NOXAFIL® (posaconazole) [Internet]. 2022 [cited 2024 Apr 25]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022003Orig1s027lbl.pdf.
  • Bayhan GI, Garipardic M, Karaman K, et al. Voriconazole-associated visual disturbances and hallucinations. Cutan Ocul Toxicol. 2016;35(1):80–82. doi: 10.3109/15569527.2015.1020544
  • Orssaud C, Guillemain R, Lillo Le Louet A. Toxic optic neuropathy due to voriconazole: possible potentiation by reduction of CYP2C19 activity. Eur Rev Med Pharmacol Sci. 2021;25(24):7823–7828. doi: 10.26355/eurrev_202112_27628
  • Zheng R, Li Y, Guo C, et al. Voriconazole Induced Hallucinations and Visual Disturbances in a Female Child: A Case Report and Literature Review. Front Pediatr. 2021;9:655327 10.3389/fped.2021.655327
  • Posso-De Los Rios CJ, Tadros E, Summerbell RC, et al. Terbinafine Resistant Trichophyton Indotineae Isolated in Patients With Superficial Dermatophyte Infection in Canadian Patients. J Cutan Med Surg. 2022;26:371–376
  • Harada K, Maeda T, Kano R. Extensive tinea corporis caused by a virulent strain of trichophyton interdigitale. J Dermatol. 2021;48(4):e190–e191. doi: 10.1111/1346-8138.15793
  • Ngo TMC, Ton Nu PA, Le CC, et al. First detection of Trichophyton indotineae causing tinea corporis in Central Vietnam. Med Mycol Case Rep. 2022;36:37–41 10.1016/j.mmcr.2022.05.004
  • Bortoluzzi P, Prigitano A, Sechi A, et al. Report of terbinafine resistant trichophyton spp. In Italy: clinical presentations, molecular identification, antifungal susceptibility testing and mutations in the squalene epoxidase gene. Mycoses. 2023;66(8):680–687. doi: 10.1111/myc.13597
  • Fattahi A, Shirvani F, Ayatollahi A, et al. Multidrug-resistant trichophyton mentagrophytes genotype VIII in an Iranian family with generalized dermatophytosis: report of four cases and review of literature. Int J Dermatol. 2021;60(6):686–692. doi: 10.1111/ijd.15226

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.